GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Other Gross PPE

Novartis AG (MEX:NVS N) Other Gross PPE : MXN226,820 Mil (As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Other Gross PPE?

Novartis AG's Other Gross PPE for the quarter that ended in Mar. 2025 was MXN226,820 Mil.

Novartis AG's quarterly Other Gross PPE declined from Sep. 2024 (MXN220,551 Mil) to Dec. 2024 (MXN1,210 Mil) but then increased from Dec. 2024 (MXN1,210 Mil) to Mar. 2025 (MXN226,820 Mil).

Novartis AG's annual Other Gross PPE declined from Dec. 2022 (MXN1,248 Mil) to Dec. 2023 (MXN1,120 Mil) but then increased from Dec. 2023 (MXN1,120 Mil) to Dec. 2024 (MXN1,210 Mil).


Novartis AG Other Gross PPE Historical Data

The historical data trend for Novartis AG's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Other Gross PPE Chart

Novartis AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 596.76 759.02 1,247.74 1,120.30 1,209.63

Novartis AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 174,957.72 194,596.13 220,551.05 1,209.63 226,820.06

Novartis AG Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Novartis AG Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines